About EURO-NMD
EURO-NMD is a Healthcare company based in Paris (France). It operates as an a network focused on rare neuromuscular diseases in Europe. It operates on a HealthTech model. EURO-NMD offers products and services including Clinical Patient Management System (CPMS), Registry Hub for Rare Neuromuscular Diseases, and Educational Resources and Webinars. Its focus areas include Rare Diseases and Neuromuscular Disorders.
Company details
EURO-NMD is a European Reference Network dedicated to rare neuromuscular diseases, addressing a wide range of disorders causing significant disability and mortality. Expertise and resources are coordinated across European healthcare providers to improve diagnosis, treatment, and patient outcomes. Research, education, and cross-border collaboration are facilitated through specialized tools like the Clinical Patient Management System and Registry Hub. Support is provided for patients and professionals in the healthcare sector.
- Headquarters Paris, France
- SectorsHealthcare
- Email••••••••
- Website ern-euro-nmd.eu
- Social LinkedIn
Products & Services of EURO-NMD
EURO-NMD offers a comprehensive portfolio of products and services, including Clinical Patient Management System (CPMS), Registry Hub for Rare Neuromuscular Diseases, and Educational Resources and Webinars.
A system for managing rare neuromuscular patient cases.
A hub for collecting rare neuromuscular disease data.
Resources and webinars for neuromuscular disease education provided.
Web traffic of EURO-NMD
Websites that share an audience with EURO-NMD (ern-euro-nmd.eu).
Websites whose visitors overlap most with EURO-NMD. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| eurordis.org | 70% | 56.8K | #660,296 | View details |
Top companies in Rare Diseases
10 companies that operate in the same segment as EURO-NMD (Rare Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Solutions for genetic diseases are developed using CRISPR-Cas9 genome editing. | 2013 | Basel, Basel-stadt, Switzerland | USD 127 M | USD 37.31 M | 393 | |
Gene therapies for rare diseases are developed to treat patients. | 2020 | Columbus, Ohio, United States | USD 250 M | – | – | |
Developing small molecules for control mechanisms and genes regulation for the treatment of rare diseases | 2015 | Cambridge, Massachusetts, United States | USD 114.67 M | – | 45 | |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies | 2010 | Boston, Massachusetts, United States | USD 84 M | USD 189.76 M | 283 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Therapies for gastrointestinal diseases are developed by Phathom Pharmaceuticals. | 2019 | Menlo Park, California, United States | USD 90 M | USD 175.11 M | 427 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EURO-NMD
EURO-NMD is headquartered in Paris, France.
EURO-NMD is a European Reference Network dedicated to rare neuromuscular diseases, addressing a wide range of disorders causing significant disability and mortality. Expertise and resources are coordinated across European healthcare providers to improve diagnosis, treatment, and patient outcomes. Research, education, and cross-border collaboration are facilitated through specialized tools like the Clinical Patient Management System and Registry Hub. Support is provided for patients and professionals in the healthcare sector.
EURO-NMD offers Clinical Patient Management System (CPMS), Registry Hub for Rare Neuromuscular Diseases, and Educational Resources and Webinars.